Advertisement

Topics

PsiOxus Therapeutics Announce Two New Board Appointments: New Board Appointments Strengthen ...

22:06 EDT 16 Aug 2017 | BioMedReports - Blog

PsiOxus Therapeutics Ltd.
John Beadle, +44 1235 42 98 40
john.beadle@psioxus.com
or
For investors:
Burns McClellan, Inc., on behalf of PsiOxus
Therapeutics Ltd.
Ben Matone, 2122130006
bmatone@burnsmc.com

Read more...

Original Article: PsiOxus Therapeutics Announce Two New Board Appointments: New Board Appointments Strengthen ...

NEXT ARTICLE

More From BioPortfolio on "PsiOxus Therapeutics Announce Two New Board Appointments: New Board Appointments Strengthen ..."

Advertisement
Quick Search
Advertisement
Advertisement